A. Iannitelli, L. Aloe, M. Fiore, G. Bersani - Vol. 7, Settembre 2001, num.3
Testo Immagini Bibliografia Summary Riassunto Indice
Variazioni nei livelli plasmatici del Nerve Growth
Factor in risposta alla Terapia Elettroconvulsivante
Changes in Nerve Growth Factor plasma levels during Electroconvulsive
Therapy
2 Gall CM, Isackson PJ. Limbic seizures increase neuronal production of messenger RNA for Nerve Growth Factor. Science 1989;245:758-61.
3 Ernfors P, Bengzon J, Kokaia Z, Persson H, Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron 1991;7:165-76.
4 Gall C, Lauterborn J, Bundman M, Murray K, Isackson P. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. In: Anderson VE, Hauser WA, Leppik IE, Noebels JL, Rich SS eds. Genetic strategies in Epilepsy research (Epilepsy Res Suppl) Elsevier Science Publishers BV, Chapter 1991;20:225-45.
5 Isackson PJ, Huntsman MM, Murray KD, Gall CM. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: temporal patterns of induction distinct from NGF. Neuron 1991;6:937-48.
6 Riva MA, Gale K, Mocchetti I. Basic fibroblast growth factor mRNA increases in specific brain regions following convulsive seizures. Mol Brain Res 1992;15:311-8.
7 Rocamora N, Palacios JM, Mengod G. Limbic seizures induce a differential regulation of the expression of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3, in the rat hippocampus. Mol Brain Res 1992;13:27-33.
8 Gall CM, Berschauer R, Isackson PJ. Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia. Mol Brain Res 1994;21:190-205.
9 Follesa P, Gale K, Mocchetti I. Regional and temporal pattern of expression of nerve growth factor and basic fibroblast growth factor mRNA in rat brain following electroconvulsive shock. Exp Neurol 1994;127:37-44.
10 Gall CM, Berschauer R, Isackson PJ. Seizures increase basic fibroblast growth factor mRNA in adult rat forebrain neurons and glia. Mol Brain Res 1994;21:190-205.
11 Lindefors N, Brodin E, Metsis M. Spatiotemporal selective effects on Brain-Derived Neurotrophic Factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 1995;65:661-70.
12 Katoh-Semba R, Takeuchi IK, Inaguama Y, Ito H, Kato K. Brain-derived neurotrophic factor, nerve growth and neurotrophin-3 selective regions of the rat brain following kainic acid-induced seizure activity. Neurosci Res 1999;35:19-29.
13 Bengzon J, Söderström S, Kokaia Z, Kokaia M, Ernfors P, Persson H, et al. Widespread increase of nerve growth factor protein in the rat forebrain after kindling-induced seizures. Brain Res 1992;587:338-42.
14 Bengzon J, Kokaia Z, Ernfors P, Kokaia M, Leanza G, Nilsson OG, et al. Regulation of neurotrophin and trkA, trkB and trkC tyrosine kinase receptor messenger RNA expression in kindling. Neuroscience 1993;53:433-46.
15 Bertram EH, Cornett J. The ontogeny of seizures in a rat model of limbic epilepsy: evidence for a kindling process in the development of chronic spontaneous seizures. Brain Res 1993;625:295-300.
16 Mody I. The molecular basis of kindling. Brain Pathol 1993;3:395-403.
17 Rashid K, Van der Zee CE, Ross GM, Chapman CA, Stanisz J, Riopelle RJ, et al. A nerve growth factor peptide retards seizure development and inhibits neuronal sprouting in a rat model of epilepsy. PNAS 1995;92:9495-9.
18 Kokaia Z, Kelly ME, Elmer E, Kokaia M, McIntyre DC, Lindvall O. Seizure-induced differential expression of messenger RNAs for neurotrophins and their receptors in genetically fast and slow kindling rats. Neuroscience 1996;75:197-207.
19 Adams B, Sazgar M, Osehobo P, Van der Zee CEEM, Diamond J, Fahnestock M, et al. Nerve Growth Factor accelerates seizure development, enhances mossy fiber sprouting, and attenuates seizure-induced decreases in neuronal density in the kindling model of epilepsy. J Neurosci 1997;17:5288-96.
20 Elmer E, Kokaia M, Ernfors P, Ferencz I, Kokaia Z, Lindvall O. Suppressed kindling epileptogenesis and perturbed BDNF and TrkB gene regulation in NT-3 mutant mice. Exp Neurol 1997;145:93-103.
21 Han D, Yamada K, Senzaki K, Xiong H, Nawa H, Nabeshima T. Involvement of nitric oxide in pentylnetetrazole-induced kindling in rats. J Neurochem 2000;74:792-8.
22 Sutula T, Cascino G, Cavazos J, Parada I, Ramirez L. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321-30.
23 Van der Zee CEEM, Rashid K, Le K, Moore K, Stanisz J, Diamond J, et al. Intraventricular administration of antibodies to nerve growth factor retards kindling and blocks mossy fiber sprouting in adult rats. J Neurosci 1995;15:5316-23.
24 Elmér E, Kokaia M, Kokaia Z, Ferencz I, Lindvall O. Delayed kindling development after rapidly recurring seizures: relation to mossy fiber sprouting and neurotrophin, GAP-43 and dynorphin gene expression. Brain Res 1996;712:19-34.
25 Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999;89:157-66.
26 Bersani G, Iannitelli A. The current and the future possible role of Nerve Growth Factor in psychiatric disorders. In: Bersani G, Iannitelli A, Aloe L, eds. NGF, from the molecule to man: behavioural aspects and psychopathology. Rivista di Psichiatria 1998;33:80-5.
27 Iannitelli A, Bersani G, Aloe L. Dati acquisiti ed ipotesi emergenti sul ruolo delle neurotrofine, in particolare dell’NGF, in patologie di natura psichiatrica. Giornale Italiano di Psicopatologia 1998;4:383-92.
28 Iannitelli A, Fiore M, Angelucci F, Bersani G. NGF e schizofrenia. Le Scienze 1999;369:84-9.
29 Aloe L, Iannitelli A, Angelucci F, Bersani G, Fiore M. Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders. Behav Pharmacol 2000;11:235-42.
30 Bersani G, Iannitelli A, Fiore M, Angelucci F, Aloe L. Data and hypotheses on the tole of nerve growth factor and other neurotrophins in psychiatric disorders. Med Hypotheses 2000;55:199-207.
31 Holtzman DM, Lowenstein DH. Selective inhibition of axon outgrowth by antibodies to NGF in a model of temporal lobe epilepsy. J Neurosci 1995;15:7062-70.
32 Lewin GR, Barde YA. Physiology of the neurotrophins. Annu Rev Neurosci 1996;19:289-317.
33 Levi-Montalcini R, Aloe L, Alleva E. A role of nerve growth factor in nervous, endocrine and immune system. Prog Neuro Endocrin Im 1990;3:1-10.
34 Fink M. A neuroendocrine theory of convulsive therapy. TINS 1980;1:25-7.
35 American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders (Ed. 4). Washington DC, American Psychiatric Association, 1994.
36 Lassner J. Anaesthesia for ECT. Anaesthesia 1998;53:12-28.
37 Bersani G, Pacitti F, Iannitelli A, Caredda M, Orsi P. Soglia convulsivante e durata di convulsione in rapporto alla risposta terapeutica nell’ECT. Giornale Italiano di Psicopatologia 1998;4(Suppl.1):30.
38 Hamilton M. Development of a rating scale for primary depression illness. Brit J Soc Clin Psychiat 1967;6:278-95.
39 Andreasen NC. Negative vs. positive schizophrenia: definition and validation. Arch Gen Psychiat 1982;39:789-94.
40 Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987;13:261-76.
41 Bracci-Laudiero L, Aloe L, Levi-Montalcini R, Buttinelli C, Schilter D, Gillessen S, et al. Multiple sclerosis patients express increased levels of b-NGF factor in cerebrospinal fluid. Neurosci Lett 1992;147:9-12.
42 Bersani G, Aloe L, Iannitelli A, Maselli P, Alleva E, Angelucci F, et al. Nerve Growth Factor plasma levels in schizophrenic patients: a pilot study. Schizophr Res 1999;37:197-203.
43 Aloe L, Alleva E, Bohm A, Levi-Montalcini R. Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream. Neurobiol 1986;83:6184-87.
44 Spillantini MG, Aloe L, Alleva E, De Simone R, Goedert M, Levi-Montalcini R. Nerve growth factor mRNA and protein increase in hypothalamus in a mouse model of aggression. Neurobiol 1989;86:8555-9.
45 De Simone R, Alleva E, Tirassa P, Aloe L. Nerve growth factor released into the bloodstream following intraspecific fighting induces mast cell degranulation in adult male mice. Brain Behav Immun 1990;4:74-81.
46 Maestripieri D, De Simone R, Aloe L, Alleva E. Social status and nerve growth factor serum levels after agonistic encounters in mice. Physiol Behav 1990;47:161-4.
47 Bigi S, Maestripieri D, Aloe L, Alleva E. NGF decreases isolation-induced aggressive behavior, while increasing adrenal volume, in adult male mice. Physiol Behav 1992;51:337-43.
48 Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes. PNAS 1994;91:10440-4.
49 Alberch J, Brito B, Notario V, Castro R. Prenatal haloperidol treatment decreases nerve growth factor receptor and mRNA in neonate rat forebrain. Neurosci Lett 1991;131:228-32.
50 Alleva E, Della Seta D, Cirulli F, Aloe L. Haloperidol treatment decreases nerve growth factor levels in the hypothalamus of adult mice. Prog Psychopharmacol Biol Psychiatry 1996;20:483-9.
51 Aloe L, Iannitelli A, Bersani G, Alleva E, Angelucci F, Maselli P, et al. Haloperidol administration in humans lowers plasma nerve growth factor level: evidence that sedation induces opposite effects to arousal. Neuropsychobiol 1997;36:65-8.
52 Gall C, Murray K, Isackson PJ. Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus. Mol Brain Res 1991;9:113-23.
53 Humpel C, Ebendal T, Cao Y, Olson L. Pentylenetetrazol seizures increase pro-Nerve Growth Factor-like immunoreactivity in the reticular thalamic nucleus and Nerve Growth Factor mRNA in the Dentate Gyrus. J Neurosci Res 1993;35:419-27.
54 Humpel C, Wetmore C, Olson L. Regulation of Brain-Derived Neurotrophic Factor messenger RNA and protein at the cellular level in pentylenetetrazol-induced epileptic seizures. Neuroscience 1993;53:909-18.
55 Marcinkiewicz M, Nagao T, Day R, Seidah NG, Chretien M, Avoli M. Pilocarpine-induced seizures are accompanied by a transient elevation in the messenger RNA expression of the prohormone convertase PC1 in rat hippocampus: comparison with nerve growth factor and brain-derived neurotrophic factor expression. Neuroscience 1997;76:425-39.
56 Elliott RC, Gall CM. Changes in activating protein 1 (AP-1) composition correspond with the profile of nerve growth factor mRNA expression in rat hippocampus after lesion-induced seizures. J Neurosci 2000;20:2142-9.
57 Mathern GW, Babb TL, Micevych PE, Blanco CE, Pretorius JK. Granule cell mRNA levels for BDNF, NGF, and NT-3 correlate with neuron losses or supragranular mossy fiber sprouting in the chronically damaged and epileptic human hippocampus. Mol Chem Neuropathol 1997;30:53-76.
58 Suzukawa J, Omori K, Okugawa G, Fujiseki Y, Heizmann CW, Inagaki C. Long-lasting c-fos and NGF mRNA expressions and loss of perikaryal parvalbumin immunoreactivity in the development of epileptogenesis after ethacrynic acid-induced seizure. Brain Res 1999;834:89-102.
59 Pancheri P. L’elettroshock tra realtà clinica e fantasia dei mass media. Giornale Italiano di Psicopatologia 1997;3:1-3.
60 Rudorfer MV, Lebowitz BD. Progress in ECT research. Am J Psychiat 1999;156:975.
61 Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 1999;15:5-26.
62 Garcia ML, Garcia VB, Isackson PJ, Windebank AJ. Long-term alterations in growth factor mRNA expression following seizures. Neuroreport 1997;8:1445-9.